TRT, Muscle and Fat Loss: The Definitive Guide

Does TRT build muscle and burn fat?

Yes, modestly. On average, randomized trials show testosterone therapy trading fat for lean tissue: about 1.6 kg (3.5 lb) more lean mass and about 1.6 kg less fat, so the scale barely moves. Those 29 trials enrolled middle-aged and older men whose average testosterone was about 314 ng/dL (10.9 nmol/L), so not every man had low testosterone. The largest reviews of trials agree on this swap, and so do the major guidelines. [1], [23], [7], [6]

Three details matter as much as the headline. First, the "lean mass" on a body scan counts everything that is not fat or bone, including water and organs, so a lean-mass gain is not all new muscle. In one small study of men with very low testosterone, about two-thirds of the gain was muscle. Second, more lean mass did not reliably mean more strength: several trials found none, and the average gain in older men was small. Third, the changes fade within months of stopping, and testosterone is not approved or recommended to build a physique or to lose weight. [24], [3], [2], [25], [22], [7]

This guide is about men with diagnosed low testosterone (hypogonadism); studies of very high research doses appear only to explain why steroid results do not carry over to TRT.

TRT, muscle and fat: the key numbers

Every major clinical guideline that addresses body composition accepts that testosterone shifts fat to lean mass in men with confirmed low testosterone. None of the current ones recommends it as a weight-loss treatment or to build muscle in men with normal levels. This table shows what each body says, checked in September 2026.

[15], [26], [27], [7], [6], [16], [28], [29], [30], [31], [32], [22], [18]

The bodies that address it accept a modest fat-for-lean shift in men with confirmed low testosterone, and no current guideline endorses testosterone for weight loss or physique; an older 2016 obesity guideline, described below, is more favorable. They differ on whether weight loss should come first when low testosterone is linked to obesity. They also differ on when to judge whether treatment is working: a first review after 3 months (EAU), 3–6 months (AUA), 3–12 months (Endocrine Society), within 6 months (BSSM) or 6–12 months (VA). The Society for Endocrinology instead expects lifelong treatment once the diagnosis is confirmed. [7], [15], [26], [16], [30], [29]

What do the trials show, in numbers?

Doserly

Fat down, lean mass up, weight unchanged

What testosterone changed in randomized trials of middle-aged and older men.

29 randomized trials, 1,083 men

Average change compared with placebo. Bars run from −3 kg (left) to +3 kg (right); the thin line is zero.

Lean (fat-free) mass

+1.6 kg

Fat mass

−1.6 kg

Body weight

No change

T4DM: 2 years, 1,007 men

Change in each group; every man was in a lifestyle program. Bars run from −6 kg to +1.5 kg; testosterone, placebo.

Fat mass: Testosterone

−4.6 kg

Fat mass: Placebo

−1.9 kg

Skeletal muscle: Testosterone

+0.4 kg

Skeletal muscle: Placebo

−1.3 kg

Lean mass includes water and organs, not only muscle. T4DM bars are changes in each group, not adjusted differences.

Why do guidelines disagree?

• Weight loss first, or treatment alongside it? The Endocrine Society's 2026 statement, the EAU and the EAA put weight loss first when low testosterone comes from obesity. The BSSM says lifestyle change alone is not first-line. A 2016 obesity guideline from the American Association of Clinical Endocrinologists (AACE) suggests testosterone with lifestyle change in men with true hypogonadism and reports weight loss and metabolic benefits, which conflicts with the EAA. Newer statements from Brazil (2026) and Obesity Canada (2025) do not recommend testosterone for weight loss or obesity. [27], [7], [6], [38], [39], [40], [16]
• When to call it a failure. Body composition changes slowly, so a 3-month review can come before the full effect; earlier review points mostly judge symptoms such as sex drive and energy. [14], [15], [16]
• Who the trials enrolled. Many muscle trials studied healthy older men with low-normal testosterone rather than men with a firm diagnosis. [10], [41], [2]

How are muscle and fat measured?

Most trials use a DXA scan, a low-dose X-ray that splits the body into fat, bone and everything else. That "everything else" is lean mass (fat-free mass): muscle, but also water, organs and skin. Studies that measured muscle directly with MRI or muscle samples show real muscle growth, but a lean-mass number alone cannot tell muscle from water. Bioimpedance, used by many home and gym scales, estimates body fat from a small electrical current. [24], [42], [43]

Results in this guide are in kilograms (1 kg is about 2.2 lb). Testosterone results appear in ng/dL in the US and nmol/L in most other countries: the TRAVERSE trial, for example, enrolled men with levels under 300 ng/dL (10.4 nmol/L). The testosterone unit converter switches between them. [44]

How does testosterone change muscle and fat?

It makes muscle fibers bigger and tilts the balance of muscle protein toward building, while estradiol, which the body makes from testosterone, does much of the work on fat. Both were measured in people. [42], [45], [46]

• Muscle fibers get thicker. In 61 healthy young men whose own testosterone was switched off and replaced with five research doses for 20 weeks, the volume of one thigh muscle changed from −4 mL at the lowest dose to +48 mL at the highest. In muscle samples from 39 of the men, fibers grew clearly larger (hypertrophy) at the two highest research doses. [42]
• Less breakdown, more building. In a trial of 12 older men with testosterone under 480 ng/dL (17 nmol/L), the 7 given testosterone in the normal range for 6 months gained lean mass because muscle protein breakdown fell. In another small study of 5 men with very low testosterone, replacement raised muscle protein building by 56%, and about 65% of their lean-mass gain was muscle. [45], [24]
• DHT is not needed. The body turns some testosterone into DHT. In a trial of 139 men, blocking that step with dutasteride (a stronger relative of the hair-loss medicine finasteride) did not reduce the lean-mass gain. [47]
• Estradiol handles much of the fat. When researchers lowered men's testosterone and estradiol on purpose, the lack of estradiol mainly caused the gain in body fat. In a year-long trial of 88 older men, the aromatase inhibitor anastrozole raised testosterone by cutting estradiol but did not improve body composition or strength, and in the 69 men in its bone study, it lowered spine bone density. [46], [48], [49]
• Low testosterone and body fat feed each other. In a European survey of 3,369 men, a BMI of 30 or more was strongly linked with low testosterone from weak brain signals (secondary hypogonadism; relative risk ratio 8.74, a link rather than proof of cause). Losing weight raises testosterone: by about 2.5 nmol/L (about 72 ng/dL) after diet-based weight loss and 7.2 nmol/L (about 208 ng/dL) after weight-loss surgery across 44 studies. [50], [51]

Does more testosterone mean more muscle?

In research studies, yes, but side effects rose with it. In healthy men aged 60 to 75 whose own testosterone was switched off, 20 weeks of five research doses changed lean mass by −0.3, +1.7, +4.2, +5.6 and +7.3 kg from lowest to highest. A hematocrit above 54%, leg swelling and prostate problems were numerically more frequent than in young men, and the authors noted a high rate of side effects at the high doses. In young men, HDL cholesterol fell as the dose rose. [52], [53]

The top doses were far above replacement, so they describe steroid-level exposure, not TRT. In treatment, prescribers aim for the normal range using blood tests and symptoms, not muscle; see the TRT dosage and blood work guides. US labels say testosterone has not been shown safe and effective for athletic performance and that abuse happens "typically at doses higher than recommended". [22], [54] The TRT vs steroids guide covers what separates the two.

What does the research show?

Most of the evidence comes from randomized trials in middle-aged and older men, including men with diabetes, obesity or frailty. Many enrolled men with low-normal testosterone, and men who start lower tend to gain more. [10], [41], [2], [55]

How much muscle and fat does TRT change?

About 1.5–2.5 kg of lean mass gained and a similar amount of fat lost over 6 to 12 months, varying by trial.

The pattern is consistent: lean mass goes up and fat goes down, while strength, walking and falls change less or not at all.

Does more lean mass mean more strength?

Not reliably. A 2023 meta-analysis of 13 trials in 2,043 men over 60 found a small strength gain (effect size 0.21), larger in injection trials (0.74) and in men who started lower. An older analysis found a moderate effect (0.53), but without one influential study it fell to 0.23. Grip strength rose about 1.6 kg of force across 7 trials in men 40 and older. [2], [59], [33]

Guidelines read this cautiously. The Endocrine Society notes that trials "have not shown consistent improvements in gait speed or measures of disability", and the EAU advises against testosterone to improve strength in ageing men. A September 2026 review of the Testosterone Trials and TRAVERSE found benefits for sexual function and mood but not energy or physical function. The EAU even describes a 2,043-man meta-analysis as showing no significant strength gain, while the 2023 analysis reports a small one: a small effect that may not change daily life much. [26], [7], [60], [2]

That matters because doctors now define age-related muscle loss (sarcopenia) mainly by low strength, not low muscle mass. [61] One trial in frail older men with walking limits did find better leg press, chest press and stair climbing, but it stopped early after heart-related problems in 23 men on testosterone vs 5 on placebo. The much larger TRAVERSE trial later found no increase in heart attacks, strokes or heart deaths (7.0% vs 7.3%; see the heart section). [62], [44]

Do you need to lift weights on TRT?

Not to gain some lean mass, but lifting is what turns it into strength.

• Training plus testosterone. In a 12-month trial of 167 healthy men around 66 with low-normal testosterone, adding gel to supervised weight training gave 1.5 kg more fat-free mass and 1.2 kg less fat than training with placebo, but no better strength or function. Without training, testosterone still improved fat and lean mass. [10]
• Which does what. In 68 men aged 60–78 with low-normal testosterone and large waists, training improved muscle function, testosterone raised lean mass, and only the combination did both. [11]
• Frail men. In 71 frail men (average age 78) in rehabilitation, 12 weeks of weekly intramuscular injections (into a muscle) increased thigh muscle area by 7.9% vs 2.4% on placebo, while strength gains came mainly from high-intensity training. [63]
• Real-world clinic data. In 214 Japanese men with low testosterone followed for a year (not randomized), lean mass rose only in men who both took testosterone and exercised at least twice a week. [64]

Steroid-level doses show much larger gains: healthy young men given a very high research dose while training gained 6.1 kg of fat-free mass in 10 weeks, far outside what TRT does. [65] For training itself, the World Health Organization advises muscle-strengthening activity on 2 or more days a week for all adults, and the CUA recommends diet and exercise together with testosterone; neither tested a plan on TRT. [66], [28]

Will TRT make me lose weight?

Not by itself. In randomized trials, weight stayed the same on average because the fat lost was replaced by about the same amount of lean mass. A 2016 meta-analysis of 59 trials (3,029 men on testosterone, 2,049 controls) agreed; the BSSM reads the trials as showing no change in weight, BMI or waist, and the EAU as no change in weight. [1], [23], [16], [7], [6]

Why do some sources promise big weight loss? Because they quote studies without a fair comparison group:

• Uncontrolled studies. Across 32 observational studies (4,513 men), weight fell 3.50 kg and waist 6.23 cm at 24 months, with no randomized comparison; the authors asked for a proper trial. [8]
• Registries. In one urology practice, 261 men on long-acting injections went from 100.1 to 92.5 kg, with no control group. In an 11-year registry where men chose whether to be treated, obese treated men lost 23.2 kg while untreated men gained 4.2 kg. Both had ties to Bayer, which makes the injection; the second was Bayer-supported, with a Bayer employee as first author. [67], [9]

The EAU says registry weight loss carries "selection bias": men who stay on treatment for years differ from men who stop or never start. [7] Labels even list weight gain: in 2 of 95 men (2.1%) in the 24-day Tlando oral testosterone trial, and UK product information says it can signal too much testosterone. [68], [69]

Does TRT burn belly fat?

Mostly the layer just below the skin; results for the deeper fat around the organs are mixed. Subcutaneous fat sits just under the skin; visceral fat sits around the organs inside the belly. [70], [35]

• Less under-skin fat, visceral unchanged. In 38 men aged 60–78 with large waists, 6 months of gel reduced subcutaneous belly fat by 3.0% while visceral fat did not change. Two trials in men with type 2 diabetes found the same pattern: in one, subcutaneous fat fell 3.3 kg compared with placebo, while the drop in visceral fat was not statistically clear. [70], [35], [71]
• Less visceral fat. In 60 lean men over 55, a year of patches stopped the visceral fat gain seen on placebo, and in men with obesity on a very-low-calorie diet, visceral fat fell more with testosterone. [72], [12]
• Waist size. In a 2026 network meta-analysis of 23 trials in men with obesity-related low testosterone, testosterone was the only option that clearly reduced waist size compared with usual care; it also raised hematocrit. [36]

The Endocrine Society guideline does describe testosterone as reducing fat inside the abdomen; the trials mainly show that this effect is smaller and less consistent than the effect on subcutaneous fat. [26]

Can TRT help you keep muscle while dieting?

Partly. In trials, testosterone made more of the weight lost come from fat, but men still lost some lean mass on strict diets, and the advantage faded after stopping.

• Very-low-calorie diet. 100 men with obesity and testosterone of 12 nmol/L (about 346 ng/dL) or lower had a 10-week very-low-calorie diet, then weight maintenance, with long-acting undecanoate injections or placebo. Testosterone gave 2.9 kg more fat loss and 3.4 kg less lean-mass loss with testosterone over 56 weeks. Both groups lost lean mass on the diet (3.9 kg vs 4.8 kg); the testosterone group regained 3.3 kg of it during maintenance. [12]
• Older men losing weight. In 83 frail men over 65 with obesity in an intensive diet and exercise program (about 9% weight loss in 6 months), gel reduced the loss of lean mass (2% vs 3%) and thigh muscle (2% vs 4%). Physical performance improved about equally (17% vs 16%). Hematocrit rose 5% vs 1%, and testosterone blunted the HDL rise the program produced. [73], [74]
• T4DM. The trial enrolled 1,007 men aged 50–74 with a large waist and prediabetes or new type 2 diabetes, all in a lifestyle program. Over 2 years, long-acting undecanoate injections reduced fat by 4.6 kg vs 1.9 kg on placebo, and skeletal muscle rose 0.4 kg while it fell 1.3 kg on placebo. Grip strength rose 1.7 kg vs fell 0.5 kg. The fat loss explained most of the lower diabetes rate (12% vs 21% at 2 years), but hematocrit went above 54% in 106 of 491 men on testosterone vs 6 of 484 on placebo. [75], [17]
• A severe deficit in young men. In 50 healthy young men with normal testosterone on a 28-day severe deficit, a weekly research dose added 2.5 kg of lean mass compared with placebo, but fat loss was the same and leg function did not improve. This was not TRT. [76]

Doserly

Dieting on testosterone, and what happened after stopping

One randomized trial: 100 men with obesity and testosterone of 12 nmol/L or lower (about 346 ng/dL).

Long-acting testosterone undecanoate injections or placebo from week 0 to week 56, then no treatment.

1. Weeks 0–10: very-low-calorie diet

   Both groups lost lean mass: −3.9 kg with testosterone, −4.8 kg with placebo.

2. Weeks 10–56: weight maintenance

   The testosterone group regained 3.3 kg of lean mass.

3. Week 56: end of treatment

   With testosterone vs placebo: 2.9 kg more fat lost and 3.4 kg less lean mass lost.

4. About 82 weeks after stopping (64 men)

   The differences were gone. The former testosterone group lost 3.7 kg more lean mass than the former placebo group while off treatment.

Each marker is a measurement from the trial; no curve is drawn between them.

Diabetes trials point the same way. In men with type 2 diabetes, testosterone cut fat and added lean mass without improving blood sugar. A larger gel trial, sponsored by the gel's maker and using bioimpedance, found no change in body fat percentage, BMI or waist. A 2026 review of 8 trials said testosterone should not be regarded as a diabetes treatment. [35], [77], [43], [78] The American Diabetes Association (2026) does not recommend it to prevent diabetes, noting that TRAVERSE, a gel trial without a lifestyle program, found no significant prevention. The BSSM differs, treating men with symptoms and prediabetes when testosterone is below 14 nmol/L (about 404 ng/dL). [79], [80], [16]

Do injections build more muscle than gels?

Injection trials showed bigger average gains, but no trial has compared the forms head to head. Across placebo-controlled trials, intramuscular injections were linked with a 5.7% rise in fat-free mass and gels or patches (transdermal, absorbed through the skin) with 1.7%, and the skin forms did not improve leg strength. The authors stress that "no RCT to date has directly compared" the routes. Strength analyses point the same way. [81], [2], [59]

Every form raises hematocrit. In a network analysis of 29 trials, the average rise was about 4.0 points with cypionate or enanthate injections, 3.0 with gel and 1.4 with patches, and 1.6 with long-acting undecanoate injections. Only the gap between cypionate or enanthate injections and patches was statistically clear, so a bigger lean-mass effect may come with a bigger red-cell effect (see the hematocrit guide, and the cypionate and gel guides). [82]

Who gains the most?

• Men who start lower. In 105 men on injections for 18 months, those starting below 264 ng/dL (9.2 nmol/L) gained 4.2% fat-free mass vs 2.7% above it (no placebo group); lower starting levels also predicted bigger strength gains. [55], [2]
• Men who exercise, as in the Japanese clinic study above. [64]
• Age matters less than side effects: older men gained as much lean mass as young men at the same research dose, with more side effects. [52]

How long does it take to see changes?

Measurable changes appear within about 3–4 months and level off by 6–12 months: a review of treatment time courses found fat mass, lean mass and strength changing within 12–16 weeks and stabilizing at 6–12 months. Guidelines give 6 months or more (CUA), 6–12 months (Society for Endocrinology) or 12 months or more (BSSM). [14], [28], [29], [16]

In a pooled analysis of 16 trials in older men, lean mass was clearly higher at 6 months, but the pooled effect at 12 months was not statistically significant. Single long trials still showed gains: +1.9 vs +0.2 kg over 3 years with patches, and a modest +0.9 kg in the 3-year TEAAM trial. See the TRT results timeline. [58], [3], [41]

What happens to muscle and fat when you stop TRT?

The gains fade. In frail older men, lean mass was 1.2 kg higher than placebo after 6 months of gel, and none of the differences remained 6 months after stopping. In men with obesity who had used testosterone during a diet, the extra fat loss and lean-mass protection were gone about 82 weeks after stopping. The former testosterone group lost 3.7 kg more lean mass while off treatment than the former placebo group. [25], [13]

About five years after T4DM ended, more former testosterone users had restarted it (6% vs 2.8%). The EAA says stopping may be considered after weight loss in obesity-linked low testosterone, while the Society for Endocrinology expects lifelong treatment for a confirmed diagnosis. See stopping TRT. [83], [6], [29]

Is testosterone ever used to treat muscle wasting?

Only in narrow cases. The Endocrine Society suggests considering short-term testosterone for men with HIV who have low testosterone and unexplained weight loss; in trials it added about 1.22 kg of lean mass. The CUA recommends testing testosterone in men with sarcopenia or HIV-related weight loss. For age-related sarcopenia itself, the sarcopenia guideline found the evidence insufficient to recommend hormones, and the 2024 international consensus paper on defining sarcopenia notes that no drug treatment currently exists. [26], [84], [28], [85], [86]

Is TRT safe for building muscle or losing fat?

Is TRT safe when the goal is muscle or fat loss?

For men with confirmed low testosterone and regular monitoring, its risks are well described and checked for, and the most common is a rise in red blood cells. For men with normal testosterone who want a better physique, no guideline or label supports it, so they take on the same risks without a proven medical benefit. [17], [7], [22]

What side effects matter most here?

• More red blood cells. In T4DM, hematocrit went above 54% in 22% of men on testosterone vs 1% on placebo; the Society for Endocrinology says this frequent rise makes the balance of benefit and risk unclear in obesity-related low testosterone. See the hematocrit guide. [17], [29]
• Fluid retention. US labels say androgens "may promote retention of sodium and water", which can cause swelling (edema), serious in people with heart, kidney or liver disease; in gel trials, leg swelling affected fewer than 1% of men. [18], [22]
• Blood pressure. All testosterone products can raise blood pressure, and FDA required warnings on every label in 2025. [87]
• Sleep apnea. In men with obesity and severe sleep apnea, injections worsened nighttime oxygen drops at 7 weeks but not at 18 weeks. In T4DM, new sleep apnea diagnoses during the trial were more common on testosterone (3.0% vs 0.4%), as self-reported in a follow-up survey of 599 men (316 vs 283). [88], [83]
• Cholesterol. HDL cholesterol fell in some trials. [77], [74]
• Fertility. Testosterone lowers sperm production, which may not fully recover in some men; the AUA advises against it for men trying to conceive. See TRT and fertility. [19], [15]

Does TRT affect the heart?

The best evidence comes from TRAVERSE, a randomized trial of about 5,200 men aged 45 to 80 with low testosterone and heart disease or high heart risk, given daily testosterone gel or a placebo gel. Among the 2,596 men who used testosterone gel and the 2,602 who used placebo gel, it found: [44]

• Heart attack, stroke or heart death: 182 men (7.0%) on testosterone vs 190 (7.3%) on placebo; hazard ratio 0.96, which met the trial's safety goal. [44]
• Heart rhythm: atrial fibrillation 3.5% vs 2.4%; nonfatal rhythm problems needing treatment 5.2% vs 3.3%. [89]
• Kidneys: acute kidney injury 2.3% vs 1.5%. [89]
• Clots: venous clots 1.7% vs 1.2%, including pulmonary embolism 0.9% vs 0.5%. [89]
• Fractures: in TRAVERSE, clinical fractures occurred in 3.50% vs 2.46% of men (91 of 2,601 vs 64 of 2,603), so testosterone did not prevent fractures. [90]
• Blood pressure: systolic pressure rose 1.0 mm Hg on testosterone and fell 0.5 mm Hg on placebo by 36 months. [89]

Doserly

TRAVERSE: absolute results

Testosterone gel (2,596 men)Placebo gel (2,602 men)

Heart attack, stroke or heart death

Testosterone 7.0% vs placebo 7.3% (182 vs 190 men; hazard ratio 0.96, 95% CI 0.78–1.17; met the 1.5 safety margin)

Nonfatal rhythm problems needing treatment

Testosterone 5.2% vs placebo 3.3%

Atrial fibrillation

Testosterone 3.5% vs placebo 2.4%

Clinical fracture

Testosterone 3.5% vs placebo 2.5% (91 of 2,601 vs 64 of 2,603 in the full analysis set)

Acute kidney injury

Testosterone 2.3% vs placebo 1.5%

Venous clots (all)

Testosterone 1.7% vs placebo 1.2%

Pulmonary embolism

Testosterone 0.9% vs placebo 0.5%

About 5,200 men aged 45–80 at high heart risk; daily gel; mean treatment 21.7 months; about 61% stopped their study gel. Not a trial of injections.

Its limits matter here. TRAVERSE tested only a daily gel, the average man used it for 21.7 months, about 61% stopped their study gel early, and it enrolled men already at high heart risk. It did not test injections, higher doses or physique use. [44], [91] The earlier TOM trial in 209 frail men over 65 was stopped early after heart-related problems in 23 men on gel vs 5 on placebo; it was small and in sick older men. [62] See TRT and heart health.

What about taking more than prescribed?

Since 2016, US testosterone labels have warned about abuse and dependence. Abuse typically involves doses above those approved, often with other anabolic steroids, and stopping above-treatment doses can bring weeks or months of withdrawal symptoms, including depression, fatigue, low sex drive and suppressed natural testosterone. Dependence has not been documented at approved doses. [54], [22]

Who should be especially cautious?

• Men with normal testosterone who want muscle. The EAU advises against testosterone in men with normal levels, and US labels require low morning levels on at least two days before starting. [7], [19]
• Men who want children now or soon. Testosterone lowers sperm production; guidelines advise against it for men trying to conceive. [15]
• Men with a high hematocrit, untreated sleep apnea, heart, kidney or liver disease, or past blood clots, because of the risks above. [29], [22], [88], [89]
• Men with prostate or breast cancer. Current US labels contraindicate testosterone in known or suspected prostate cancer. In June 2026 FDA requested narrowing this to metastatic prostate cancer; that request is pending and not yet in any label (checked September 2026). [22], [92]
• Drug-tested athletes. Testosterone is banned in sport at all times. [21]
• Under-18s. Testosterone for teenagers belongs only in specialist care.
• Women. This guide is written for men. Testosterone for women uses different doses and products; see testosterone therapy for women.

Which medicines and supplements matter?

• GLP-1 medicines (semaglutide in Ozempic and Wegovy; tirzepatide in Mounjaro and Zepbound). No current US label lists an interaction with testosterone (checked September 2026); see below. [93]
• Corticosteroids may add to fluid retention, and testosterone may lower blood sugar and insulin needs. [68]
• Aromatase inhibitors and finasteride are covered under how it works.

Bring a complete list of what you take, including supplements, to a pharmacist or prescriber.

Is testosterone legal, and is it allowed in sport?

Checked September 2026. Rules differ by country and change often.

• United States. Testosterone and its esters are Schedule III controlled substances, prescription only; no proposal to change that has been published. In June 2026, HHS announced that FDA is requesting label changes, including removing the statement that safety and efficacy in "age-related hypogonadism" have not been established; these are requests, not yet in any label. [20], [92]
• United Kingdom. Testosterone is a Class C controlled drug, in Schedule 4 Part II. [94], [95]
• Canada. Testosterone is a Schedule IV controlled substance. [96]
• Australia. Testosterone is a Schedule 4 prescription-only medicine. [97]
• Sport. The World Anti-Doping Agency (WADA) prohibits testosterone at all times, and its 2027 list keeps the ban. An exemption is granted only for low testosterone with an organic cause, not for age, obesity or overtraining. Semaglutide and tirzepatide are only on WADA's monitoring program. [21], [98], [99], [100]

What do guidelines say to do?

Confirm low testosterone, lose weight first when obesity is the likely cause (in most guidelines), combine treatment with diet and training, and review it after a few months. This describes the choices clinicians weigh; it is not a personal plan.

[15], [26], [27], [7], [6], [29], [16], [28], [30], [39], [40], [32]

Can you take TRT just for muscle or fat loss?

No guideline supports it. The EAU advises against testosterone in men with normal levels. US labels require low levels on at least two mornings and say it has not been shown safe and effective for athletic performance. The Endocrine Society's 2026 statement says symptoms alone do not make a diagnosis and reversible causes such as obesity, corticosteroids and opioids come first. [7], [19], [22], [27]

Obesity also makes one test harder to read: it lowers SHBG, the protein that carries testosterone, so total testosterone can read low while free testosterone stays normal, a pattern the VA notes. The AUA recommends testing men with a BMI of 30 or more or a waist over 40 inches. [30], [15] See the low testosterone guide.

When should you decide whether it is working?

At the review your prescriber sets, usually 3 to 6 months after starting (EAU after 3 months, AUA 3–6 months, Endocrine Society 3–12 months, BSSM 6 months, VA 6–12 months). Body composition can still be changing then, so the review is also a chance to check hematocrit, blood pressure and whether diet and training changed at the same time. [7], [15], [26], [16], [30], [14]

How do dieting, GLP-1 medicines and training fit with TRT?

Should you lose weight before starting TRT?

Most guidelines say yes when obesity is the likely cause, because losing weight raises testosterone on its own; the BSSM and AUA will treat alongside weight loss when symptoms are clear (see why guidelines disagree). [27], [7], [16], [15] The rise depends on how much weight comes off: about 2.9 nmol/L (84 ng/dL) with a low-calorie diet and 8.7 nmol/L (251 ng/dL) after weight-loss surgery in one meta-analysis. In a European study of 2,395 men followed for 4.4 years, free testosterone changed only with a 15% or larger change in weight. [101], [102] The obesity-related low testosterone guide covers this in depth.

Why did I gain weight in my first weeks on TRT?

Usually a mix of more food, more training and some retained water, but no study has measured how much is water. Labels say androgens may cause salt and water retention. Swelling in the ankles or legs, or sudden weight gain with breathlessness, needs a medical check, especially with heart, kidney or liver disease. [18], [22] Over months, trials show lean mass rising and fat falling by similar amounts, so a waist measurement or the fit of your clothes says more than the scale. [1]

Can you take TRT with Ozempic, Wegovy or Mounjaro?

No label lists an interaction (checked September 2026), but no randomized trial has tested whether testosterone protects muscle during GLP-1 weight loss. [93], [103]

• GLP-1 weight loss includes lean mass. In a body-scan substudy of the tirzepatide trial SURMOUNT-1 (160 adults, 73% women), 74% of the weight lost was fat and 26% lean mass, the same split as on placebo; tirzepatide simply caused more weight loss. In the semaglutide trial STEP 1, lean mass fell 9.7% and fat 19.3% (a conference report of 140 adults, 76% women). [104], [105]
• The only combined data are uncontrolled. In one clinic's records of 93 men with obesity on tirzepatide, testosterone and coaching, lean body mass fell 4.0–6.1 kg over 12 months, while muscle estimated by bioimpedance rose 1.6–3.7 kg and grip strength rose 5.7–7.1 kg. The authors say the design "precludes attribution" to any single part. [103]
• GLP-1 medicines raise testosterone too. In a 16-week trial in men with obesity, liraglutide raised testosterone by 2.6 nmol/L (75 ng/dL) and cut weight by 7.9 kg, while testosterone gel raised testosterone by 5.9 nmol/L (170 ng/dL) with 0.9 kg of weight loss. [106]

Retatrutide, which some men combine with testosterone, is not approved anywhere (checked September 2026); see the retatrutide guide. The TRT with GLP-1 medicines guide covers the combination in full.

How much protein and training do you need?

No trial has set targets for men on TRT. In healthy people doing resistance training, protein supplements added about 0.3 kg of fat-free mass, with no further gain once total protein reached about 1.6 g per kg of body weight a day. The WHO advises strength work on 2 or more days a week, and the sarcopenia guideline strongly recommends resistance training for older adults with muscle loss. [107], [66], [85] See the whey protein and creatine guides.

Does an aromatase inhibitor help you lean out?

No trial shows that it does: estradiol helps control body fat in men, and anastrozole did not improve body composition or strength in older men while lowering spine bone density (how it works). See estrogen on TRT. [46], [48], [49]

Are enclomiphene and TRT the same for body composition?

Nobody knows yet: we found no trial comparing their effects on muscle and fat. They differ for fertility: in two trials in overweight men, enclomiphene raised testosterone while keeping sperm counts normal, whereas testosterone gel markedly reduced sperm production. [108] See the enclomiphene guide and TRT and fertility.

Is TRT the same as taking steroids for bodybuilding?

No. TRT brings low testosterone back into the normal range; bodybuilding cycles use much higher (supraphysiologic) doses, often with other steroids, the source of both the big gains and the label warnings. [65], [22] See TRT vs steroids.

What do men on TRT report about muscle and fat?

Public forums are full of transformation photos, stalled scales and questions about water weight. The threads below are public Reddit discussions from the past year, read with their replies; they show what people experience, not how often, and most combine testosterone with other changes.

What do positive reports look like?

Most describe strength and training quality first, and body changes over months. A man in his 50s on 70 mg a week posted three scans from the same machine over about 11 months: lean mass up 13.0 lb and fat down 25.4 lb. He was also taking two weight-loss drugs (one unapproved), creatine and a new training program. He noticed gains around month three. [109] A longtime lifter in his 30s reported about 20 lb gained on a dose raised to 200 mg a week, which he himself called "hardly trt maintenance", and named faster recovery as the clearest benefit. [110]

A man in his 40s who had lost 73 lb by diet before restarting treatment went from about 193 to 210 lb in six months, with a bench-press record, while eating about 200 more calories a day. [111] A man in his 30s lost 164 lb over two years on tirzepatide, with testosterone for the last six months. He credited the GLP-1 medicine for appetite, TRT for motivation and recovery, and walking and protein for "the real long term work". [112]

Why does the scale go up in the first weeks?

It is one of the most common worries. Reported gains in the first one to three months range from about 6 lb to 15 lb, and most posters had also changed food, training or both. Examples include 8 lb in seven weeks after restarting daily walking and some lifting, and 15 lb in a month after switching from one meal a day to several meals and protein shakes. Another man gained 6–7 lb in about 10 days, four weeks in, after months at a stable weight on tirzepatide. [113], [114], [115] A fourth, 12 weeks in, was up 9 lb after also starting creatine but said clothes fit better every day. [116]

Some stories are less clear-cut. One poster, weighing about 350 lb, reported nearly 20 lb gained in the first three weeks of a third attempt at TRT, as in two earlier attempts, alongside about two sodas with every meal. Another gained 15 lb in the two weeks after starting an aromatase inhibitor. [117], [118]

What about men who gained little or nothing?

Nonresponse comes up often. A man in his 30s on 100 mg a week for two years, with testosterone up from 280 to 410 ng/dL (9.7 to 14.2 nmol/L), reported little muscle or strength gain despite tracking protein and lifts. He asked about raising the dose, a decision for a prescriber. [119] A man on tirzepatide who had lost about 100 lb said his doctor doubled his dose after the clinic's body-composition checks showed little muscle gain, although his testosterone results were already high. He was also getting conflicting calorie advice from his rehabilitation doctor, his trainer and his testosterone doctor. [120] Another man stopped after seven months of feeling no better and gaining almost 20 lb without a strength change; after tapering off with enclomiphene, he reported losing almost 15 lb and improving some lifts a month later. [121]

What do people report when combining GLP-1 medicines?

Big losses on the scale, and worries about looking soft. A man who lost 34 lb on tirzepatide without lifting had a scan showing 28.5% body fat before starting prescribed testosterone and weight training. Another called Zepbound the "game changer" in losing 57 lb, and a man on retatrutide and testosterone reported a stalled scale while forcing himself to eat to hit protein targets. [122], [123], [124]

Several men asked whether to lose weight first. One man in his 20s, whose doctor blamed his low testosterone on weight and insulin resistance, turned down a 6-month course his trainer suggested, partly because he wants children. Another, 63 lb down on Zepbound, chose more weight loss and further hormone tests first. [125], [126] A man who started at about 25% body fat stopped after three weeks because of acne, facial bloating, weaker erections and a flare of old breast-tissue swelling, planning to lose weight first. [127]

What unwanted effects come up?

Beyond the scale, three accounts stand out. One man said an aromatase inhibitor improved his erections but brought headaches and worse gym performance. Another reached a hematocrit above 54% on a higher dose, then lowered the dose, gave blood and switched to subcutaneous injections (into the fatty layer under the skin), with upper-body strength dipping for a while. A third man, with a total testosterone of 1,664 ng/dL (57.7 nmol/L) four months in, stopped after whole-body muscle stiffness and cramping that he tied to each injection. [128], [129], [130]

How can you judge a transformation story?

Ask: Was low testosterone confirmed before treatment? What dose, and did it change? What else changed at the same time: diet, training, weight-loss medicines, other hormones or drugs? Was body fat measured the same way before and after? Is there a later update?

Some "TRT transformations" are not TRT at all: one four-year recomposition post included a later non-prescribed cycle of several steroids, and another man whose testosterone was already in the normal range described his new prescription as a cycle. [131], [132] Meanwhile a man three months into treatment asked whether he was "wasting" TRT by not lifting, after better energy and sleep but no measured change in his body. [133]

These selected discussions show what people experience and the questions research has not answered. They are not a survey of all men on TRT, a success rate or a substitute for the trials above.

What should you track?

Guidelines monitor testosterone, hematocrit, the prostate blood test PSA, blood pressure and symptoms; none reviewed lists repeat DXA scans for tracking physique. For your own goals, simple measures taken the same way each time work best. Use this to prepare questions for your prescriber; it is not a personal testing plan. [26], [15]

[26], [15], [87], [16], [30], [2], [18], [88]

If you want a body scan, use the same machine each time so the results are comparable. The TRT blood work guide covers when to draw each test.

Common questions about TRT, muscle and fat

How much muscle can I expect to gain on TRT?

On average, about 1.5 to 2.5 kg (about 3 to 5.5 lb) of lean mass over 6 to 12 months in randomized trials, and not all of it is muscle. Men who start with lower testosterone and who lift tend to gain more, while strength gains are usually small without training. [1], [33], [55], [10] See the research.

Why isn't the scale moving if TRT is working?

Because fat and lean mass change by similar amounts, so weight stays about the same; that is what randomized trials found on average. A waist measurement, how clothes fit or a repeat body scan on the same machine show the change better, and weight gain in the first weeks often comes from more food, more training and some water. [1], [7], [18] See the weight question.

Can I lose weight on TRT without exercise?

Trials without exercise programs still found less fat and more lean mass, but no average weight loss; the biggest fat losses came with a diet or lifestyle program, as in T4DM (4.6 kg vs 1.9 kg on placebo). [1], [10], [75] See dieting on TRT.

Will I lose my gains if I stop TRT?

Probably, over months. In trials, the extra lean mass and fat loss were gone within 6 months of stopping in frail older men and by about 82 weeks in men with obesity who had dieted. The former testosterone group also lost more lean mass while off treatment. [25], [13] See stopping.

Does finasteride stop TRT from building muscle?

Probably not. In a research trial, blocking the conversion of testosterone to DHT with dutasteride, a stronger relative of finasteride, did not reduce the lean-mass gain; the researchers concluded DHT is not essential for testosterone's effect on muscle. [47] See how it works.

Is a DXA scan necessary on TRT?

No. Guidelines monitor testosterone, hematocrit, PSA, blood pressure and symptoms, and none reviewed lists repeat body scans for tracking physique. A scan can be useful if you want an objective measure, as long as repeat scans use the same machine. [26], [15] See what to track.

Glossary

Plain explanations of the medical, body-composition and research terms used in this guide. Underlined terms in the text link here.

Aromatase inhibitor

A medicine, such as anastrozole, that blocks the enzyme that turns testosterone into estradiol. In a trial of older men it did not improve body composition or strength.

Bioimpedance (BIA)

A way of estimating body fat by passing a tiny electrical current through the body, used by many home and gym scales. It is an estimate, not a direct measurement.

Clinical guideline

Recommendations written by a medical society or health system, based on its review of the evidence and expert judgment. Different guidelines can reach different conclusions.

Cohort study (records study)

A study that follows a group of people, or looks back at their records, without assigning treatments. It can show links but not prove that one thing caused another.

Controlled trial

A study that compares people who receive a treatment with a similar group who do not, often receiving a placebo instead. Randomly assigning people to each group makes the comparison fairer.

DHT (dihydrotestosterone)

A stronger hormone the body makes from testosterone in the skin, hair follicles and prostate. Finasteride and dutasteride block its production. It is not needed for testosterone's effect on muscle.

DXA scan

Dual-energy X-ray absorptiometry: a low-dose X-ray scan that splits the body into fat, bone and lean mass. It is the usual way trials measure body composition.

Edema

Swelling from fluid held in the body's tissues, often in the ankles, hands or face.

Effect size

A standard way of saying how big a difference is, so studies with different measurements can be combined. As a rough guide, 0.2 is small, 0.5 moderate and 0.8 large.

Estradiol

The main form of estrogen. In men it is made mostly from testosterone, and it helps control body fat and bone strength.

Fat mass

The total weight of fat in the body, as measured by a body-composition scan.

Hazard ratio

A measure comparing how often an event happens over time in two groups. A hazard ratio of 1 means no difference; 0.96 means about 4% lower in the first group.

HDL cholesterol

Often called 'good' cholesterol because higher levels go with lower heart risk. Testosterone lowered it in some trials.

Hematocrit

The share of the blood made up of red blood cells. Testosterone therapy can raise it, which is why it is checked.

Hypertrophy

Growth of a tissue because its cells get bigger. Testosterone makes muscle fibers thicker.

Hypogonadism

Low testosterone caused by a problem in the testicles or in the brain and pituitary signals that control them, confirmed with symptoms and repeated morning blood tests.

Intramuscular (IM)

Injected into a muscle. Most testosterone cypionate and enanthate is given this way.

Product label (prescribing information)

The official document approved by a medicines regulator for a product, describing its approved uses, doses, warnings and monitoring. In the UK it is called the summary of product characteristics.

Lean mass (fat-free mass)

Everything in the body that is not fat (or, on a DXA scan, not fat or bone): muscle, but also water, organs and skin. A lean-mass gain is not all muscle.

Meta-analysis and systematic review

A systematic review gathers all studies on a question in a planned way. A meta-analysis combines their results statistically. A network meta-analysis compares several treatments at once, even ones never tested head to head.

Placebo

A dummy treatment with no active ingredient, used as a comparison in studies.

Registry study

A long-term record of patients on a treatment, often without a randomized comparison group. It shows what happened over time, not what the treatment caused.

Sarcopenia

Age-related loss of muscle strength and mass. Current definitions put low strength first.

SHBG (sex hormone-binding globulin)

A blood protein that carries testosterone. Obesity lowers it, so total testosterone can read low while free testosterone is normal.

Subcutaneous (SC)

Injected into the fatty layer just under the skin. Xyosted is given this way, and some prescribers use this route for other testosterone injections.

Subcutaneous fat

The fat just under the skin, the kind you can pinch. Testosterone therapy reduced it more consistently than visceral fat in trials.

Supraphysiologic dose

A dose that pushes testosterone well above the normal range, as in bodybuilding cycles and some research studies. TRT aims for the normal range.

Transdermal

Absorbed through the skin, as with testosterone gels and patches.

TRT (testosterone replacement therapy)

Prescribed testosterone, by injection, gel or other forms, for men with low testosterone. It switches off the brain's LH and FSH signals.

Visceral fat

Fat inside the belly around the organs. It is more closely linked with diabetes and heart disease than subcutaneous fat.

WADA

The World Anti-Doping Agency, which publishes the list of substances banned in sport. Testosterone is prohibited at all times.

How this guide was researched

This guide is built from a thorough review of the sources cited throughout it: guidelines and consensus statements from 18 medical and public-health bodies, product labels, published randomized trials and other studies, trial reviews and regulatory documents. We also reviewed public online forums where men on TRT describe their own changes in muscle, fat and weight.

The guide cites 133 sources, including 51 original studies in people, 19 clinical guidelines, consensus statements and position statements, and 25 public community discussions. Each type of source answers a different question. Guidelines and labels show what clinicians are told to do. Trials and studies show what was measured. Personal accounts show what individual people experienced. Every numbered citation links to its entry below, labeled by source type.

How this guide was made

Research and drafting were AI-assisted. Every cited source was checked against the original, and the guide was reviewed and edited by Doserly before publication. It has not had an independent clinical review, and Doserly does not currently have medical reviewers. Doserly makes a medication and health-tracking app and runs Doserly Academy, both of which are promoted in this guide. Read our editorial policy for how guides are researched, updated and corrected.

This guide is for educational purposes. It summarizes what the reviewed sources report so the research is easier to understand; it is not medical advice. For a deeper dive, or to check any point for yourself, go straight to the cited sources.

Explore the sources